Japan’s Flourishing Regenerative Medicine Market
Both foreign and domestic companies are benefitting from Japan’s revised classification system that was implemented in November 2014. The new classification system separated regenerative medical products from medical devices and streamlined the approval process. Rather than undergo a lengthy clinical trial process... Read More